With a revenue increase of 58.12% in the third quarter 2026, year on year to cumulative value of $946 million, Kiniksa Pharmaceuticals International Plc's revenue per employee grew on a trailing twelve months basis to $ 2,584,598, this is below the company average.
Within the Healthcare sector Employees of 3 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 125, from total ranking in previous quarter at 365. Kiniksa Pharmaceuticals International Plc has 366 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KNSA Revenue per Employee	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Revenue Change	58.12 %	55.36 %	55.51 %	64.95 %	61.17 %
Sales per Employee (TTM) $	2,584,598	2,297,399	2,060,232	1,851,268	1,633,806
KNSA's Total Ranking	# 125	# 365	# 189	#	#
Seq. Revenue Change	17.39 %	13.69 %	6.01 %	11.76 %	15.34 %

KNSA Company Profile >> Back to KNSA Efficiency Comparisons >> Compare KNSA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 1
Healthcare Sector	# 4
Overall Market	# 125

Revenue per Employee Statistics
High	Average	Low
$ 2,060,232	$ 977,540	$ 193,260
(Mar 31 2026)		(Mar 31 2022)

Financial Statements
Kiniksa Pharmaceuticals International Plc's Revenue MRQ	$ 286 Millions	Visit KNSA's Income Statement
Kiniksa Pharmaceuticals International Plc's Revenues TTM	$ 946 Millions	Visit KNSA's aggregate revenue growth
What are KNSA's Sales?		Visit KNSA's Sales by Segment

Other Ratios
Kiniksa Pharmaceuticals International Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KNSA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KNSA's Competitors
Revenue per Employee for KNSA's Suppliers
Revenue per Employee for KNSA's Customers

You may also want to know
KNSA's Sales Growth Rates	KNSA's Pe Price to earnings ratio	KNSA's Receivables Turnover Ratio	KNSA's Stock Quote
KNSA's Net Income Growth Rates	KNSA's Ps Price to Sales ratio	KNSA's Sales per Employee	KNSA's Asset Turnover Ratio
KNSA's Net Margin	KNSA's Pb Price to Book ratio	KNSA's Financial Strength Ratios	KNSA's Dividend Payout Ratio

Date modified: 2026-10-28T09:26:31+00:00

Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Sep 30 2026	Number of Employees Sep 30 2026
Halozyme Therapeutics Inc	4,261,106.38	$ 1,802.448 Million	423
Ironwood Pharmaceuticals inc	4,002,960.00	$ 400.296 Million	100
Community Health Systems Inc	3,759,032.26	$ 11,653.000 Million	3,100
Illumina Inc	3,545,312.50	$ 4,538.000 Million	1,280
Kiniksa Pharmaceuticals International Plc	2,584,598.36	$ 945.963 Million	366
Aurinia Pharmaceuticals Inc	2,513,578.12	$ 321.738 Million	128
Sarepta Therapeutics Inc	2,342,920.96	$ 1,956.339 Million	835
Zevra Therapeutics Inc	2,304,065.57	$ 140.548 Million	61
Nurix Therapeutics Inc	2,214,309.15	$ 701.936 Million	317
Exelixis Inc	2,176,862.25	$ 2,496.861 Million	1,147
Incyte Corporation	2,113,485.94	$ 6,010.754 Million	2,844
Alnylam Pharmaceuticals Inc	2,005,296.80	$ 5,013.242 Million	2,500
Neurocrine Biosciences Inc	1,850,850.00	$ 3,701.700 Million	2,000
Tarsus Pharmaceuticals Inc	1,843,791.89	$ 682.203 Million	370
Gilead Sciences Inc	1,822,823.53	$ 30,988.000 Million	17,000
Mirum Pharmaceuticals Inc	1,803,166.67	$ 670.778 Million	372
Eli Lilly And Company	1,729,240.00	$ 86,462.000 Million	50,000
Alector Inc	1,684,165.05	$ 173.469 Million	103
Rigel Pharmaceuticals Inc	1,656,396.55	$ 288.213 Million	174
Jazz Pharmaceuticals Plc	1,632,569.55	$ 4,718.126 Million	2,890
Krystal Biotech Inc	1,593,305.08	$ 470.025 Million	295
Madrigal Pharmaceuticals Inc	1,560,590.16	$ 1,427.940 Million	915
Bristol myers Squibb Company	1,539,476.92	$ 50,033.000 Million	32,500
Acadia Pharmaceuticals Inc	1,506,642.86	$ 1,202.301 Million	798
Indivior Pharmaceuticals Inc	1,376,000.00	$ 1,376.000 Million	1,000
Biogen Inc	1,372,973.33	$ 10,297.300 Million	7,500
Supernus Pharmaceuticals inc	1,326,849.69	$ 865.106 Million	652
Corcept Therapeutics Inc	1,320,064.38	$ 963.647 Million	730
Travere Therapeutics Inc	1,309,927.57	$ 651.034 Million	497
Lantheus Holdings Inc	1,309,212.07	$ 1,561.890 Million	1,193

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.